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Case Report 
Pulmonary Edema in Malaria 
Amar Safdar, MD;* Barry J. Hartman, MD;+ Bradley A. Connor, MD;+ and Henry W Murray, MD+ 
Two patients, hospitalized in NewYork City with malaria 
caused by Plasmodium falciparum, developed pul- 
monary edema while responding to antimalarial therapy. 
These cases serve as a timely reminder of this serious 
pulmonary complication of malaria. 
CASE REPORTS 
Patient 1 
A 33-year-old Australian woman, who had been stationed 
in Liberia for 4 months, flew to New York City for vaca- 
tion. Several days later, she developed fever, rigors, lower 
back pain, and headache. On the third day of symptoms, 
she was acutely ill and was admitted to The New York 
Hospital where a peripheral blood smear showed char- 
acteristic ring forms of Pfalciparum (Figure 1). She had 
discontinued chloroquine and proguanil prophylaxis due 
to gastrointestinal intolerance 10 weeks before admis- 
sion. Initial laboratory studies included white blood cell 
(WBC) count of 4800/mm3; hemoglobin, 11.9 g/dL; hema- 
tocrit, 34%; platelet count, 43,000/mm3; lactic dehydro- 
genase (LDH), 399 IU; prothrombin time (PT), 14.7 
seconds (control 12.0 s); and partial thromboplastin time 
m, 35.1 seconds (control 38 s). Admission chest exam- 
ination and roentgenogram were normal (Figure 2, A). 
After 18 hours of treatment with oral quinine and 
doxycycline, parasitemia was reduced from 2. IL to 1.2%. 
However, 12 hours later, the patient developed acute res- 
piratory distress with severe hypoxemia (arterial PO, 
38 mmHg breathing room air). Bronchial breath sounds 
and rales were heard over both lower lung fields. Fever 
to 39°C persisted, although parasitemia was less than 
0.1%. The patient developed evidence suggesting coagu- 
lopathy or disseminated intravascular coagulation (DIG) 
with a further increase in PT to15.4 seconds and a pos- 
itive D-dimer test. Repeat chest x-ray was consistent with 
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pulmonary edema (see Figure 2, B). In the 24 hours prior 
to the onset of respiratory distress, the patient had 
received normal saline intravenously at a rate of 150 cc 
per hour. Serial electrocardiograms (EKG), cardiac 
enzymes, transthoracic echocardiogram, and a ventilation- 
perfusion scan were all normal. 
Although the patient had no clinical evidence of fluid 
overload, she received furosemide and responded with a 
diuresis of 2 liters of urine over 24 hours. Despite this, 
there was essentially no improvement in oxygenation 
(arterial PO,, 63 mmHg, while receiving 100% oxygen). 
Two days later clinical and radiographic findings began 
to improve and evidence of coagulopathy began to 
resolve. Antimalarial therapy was stopped after 7 days, 
and the patient was discharged on day 8 with a normal 
chest roentgenogram. 
Patient 2 
A 35-year-old French-Haitian woman, who lived in New 
York City, presented to The New York Hospital with 2 
days of high fever (4O”Q rigors, drenching sweats, and 
headache. Her symptoms started 7 days after a 5-day trip 
Figure 1. Giemsa-stained admission peripheral blood smear. Arrows 
indicate characteristic intra-etythrocytic ring and multiple appliqu6 forms 
(merozoites) of P falciparum. 
217 
218 International Journal of Infectious Diseases / Volume 3, Number 4, 1999 
Figure 2. A, Normal admission chest roentgenogram. B, Chest 
roentgenogram on the fourth hospital day showing bilateral mid- and 
lower-lung field infiltrates. 
with her husband to a remote beach resort in Haiti. The 
patient’s husband also had been hospitalized 2 days ear- 
lier, with similar symptoms caused by P falciparum 
malaria. On admission, she was acutely ill appearing, with 
a WBC count of 3400/mm3; hemoglobin, 14.0 g/dL; hema- 
tocrit, 43%; platelet count, 1 10,000/mm3; LDH, 510 IU; PT, 
12 seconds; and PTT, 36 seconds. Admission chest exam- 
ination and chest x-ray were normal. Her peripheral blood 
smear showed Pfalciparum infection (0.1% parasitemia), 
and a total of 2.5 g of oral chloroquine phosphate was 
given over the next 48 hours. 
On the second hospital day, parasitemia was less than 
0.05%; however, the patient complained of progressive 
dyspnea and cough and was found to have diminished 
breath sounds at the lung bases. Chest roentgenogram 
showed diffuse infiltrates extending from the hilum with 
a normal cardiac silhouette. Because of the possibility of 
fluid overload, she was treated with furosemide with 
prompt diuresis. Despite a negative fluid balance of 
2.1 liters, she developed acute respiratory failure on the 
fourth hospital day (PO,, 48 mmHg, while receiving 100% 
oxygen) and required mechanical ventilation and posi- 
tive end-expiratory pressure (15 cm HzO). Repeat chest 
x-ray showed a pulmonary edema pattern and normal 
heart size, consistent with the adult respiratory distress 
syndrome (ARDS). At this time, blood studies revealed 
hemoglobin, 8.2 g/dL; platelet count, 62,000/mm3; PT, 
13.6 seconds; and elevated fibrin degradation products 
(FDP) suggesting coagulopathy. Serial EKGs, cardiac 
enzymes, transthoracic echocardiogram, and pulmonary 
capillary wedge pressure were all normal 
After 48 hours of mechanical ventilation, the patient 
started to show improvement. Her hospital course was 
extended, owing to a left pneumothorax and Serratia 
marcescens nosocomial pneumonia. On discharge, her 
chest roentgenograph had returned to normal. The 
patient’s husband, who responded promptly to chloro- 
quine therapy, had an uneventful hospital stay. 
DISCUSSION 
Since the turn of the century, respiratory complications 
in patients with acute l?falciparum malaria have varied 
from minor symptoms consistent with bronchitis to full- 
blown respiratory failure, and even fatal pulmonary 
apoplexy.’ The overaIl incidence of respiratory compli- 
cations in this infection ranges from 3% to 10%.2*3 
Pulmonary complications during the course of 
malaria historically bear a high mortality rate.l-s In one 
series of 12 cases, mortality was 75%, with more than 
half the deaths occurring during the first 24 hours.5 In 
surviving patients, clinical improvement occurred 72 to 
96 hours following the onset of the acute respiratory 
episode. In Africa, patients with cerebral malaria due to 
I?falciparum appear more likely to develop respiratory 
complications7~s; observations in Far East Asia also have 
suggested a separate association between DIC and ARDS 
in Pfalciparum malaria.5 
The earlier concept of renal insufficiency combined 
with fluid overload as the cause of respiratory failure in 
I?falca$arum malaria has been replaced by the notion of 
a capillary-alveolar leak phenomenon.‘Jz9 Fein and col- 
leagues reported a well-documented case of acute non- 
cardiogenic pulmonary edema during the early phase of 
Pfalciparum therapy,lO thereby supporting, as also illus- 
trated by the two cases herein described, the current 
hypothesis of primary lung injury as a cause of respira- 
tory compromise during malaria. High circulating levels 
of inflammatory cytokines, such as tumor necrosis fac- 
tor-o, may be a target for additional treatment.“-l3 
Whether the use of heparin for malaria-associated coag- 
ulopathy and DIC or corticosteroids for cerebral malaria 
has a beneficial effect on concomitant ARDS is not clear.4,5 
In the majority of the reported malaria cases in which 
an ARDS-like scenario developed, respiratory failure 
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occurred during or immediately following an adequate 
antiparasitic response to treatment.‘-” Both of the 
patients described in this case report demonstrated this 
timing. The typical onset of respiratory complications is 
within 5 to 7 days of first malarial symptomsi; rarely, pul- 
monary complications may be delayed. 
The management of ARDS related to malaria does 
not differ from ARDS associated with other disorders 
except for giving proper therapy for malaria itseK1*J5 
No association has been found with the degree or 
duration of the initial parasitemia and subsequent pul- 
monary complications.5-10 These two patients developed 
respiratory failure in the presence of nearly undetectable 
levels of parasitemia. 
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